NCT01754818View on ClinicalTrials.gov

A Phase 1 Study Examining the Pharmacokinetics and Tolerability of a Single Oral Dose of Bendavia (MTP-131)

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

January 31, 2013

Study Completion Date

February 28, 2013

Conditions

Healthy

Interventions

DRUG

Bendavia 10mg

DRUG

Bendavia 50mg

DRUG

Bendavia 100mg

DRUG

Placebo

Trial Locations (1)

33014

Clinical Pharmacology of Miami, Miami

All Listed Sponsors

lead

Stealth BioTherapeutics Inc.

INDUSTRY

NCT01754818 - A Phase 1 Study Examining the Pharmacokinetics and Tolerability of a Single Oral Dose of Bendavia (MTP-131) | Biotech Hunter | Biotech Hunter